Comparison of Pharmacokinetic Profiles of Two Nicotine Gum Formulations
Status:
Completed
Trial end date:
2013-06-01
Target enrollment:
Participant gender:
Summary
The primary objective of this study is to compare pharmacokinetic (PK) profiles and assess
the bioequivalence between the newly developed nicotine gums (2 mg and 4 mg) and the
reference nicotine gums (2 mg and 4 mg) in healthy smokers.